tereotactic radiosurgery for treatment of intracranial AVMs has been a well-established alternative to open AVM resection or embolization. Studies in which GKS, particle-beam, and LINAC radiosurgical systems were used have all reported successful experiences, typically citing occlusion rates between 60 and 80%, with relatively low (2%) complication rates. 1, 4, 5, 11, 12, 18, 26, 27, 30, 31, 40, 44, 48, [50] [51] [52] [53] Investigators have identified multiple factors predictive of radiosurgical success. 7, 9, 13, 14, 17, 18, 25, 26, 29, 31, 40, 44, 47 Lower AVM volume, fewer draining veins, younger patient age, superficial lesion location, and radiation dose up to 20 Gy are among other factors found to be predictive of AVM obliteration. 40 Grading systems have been developed to facilitate treatment planning. The K index, the product of the cube root of the AVM volume and peripheral dose, has been thought to serve as a good predictor of success. 26 The obliteration prediction index, 45 which is calculated by dividing the marginal dose of radiation by AVM diameter, has also been found to be predictive of obliteration. The Spetzler-Martin grading system 49 was developed to predict AVM outcome after microsurgery, based on AVM size, eloquence of adjacent brain, and pattern of venous drainage. This system has been established in the litera- Object. The radiosurgery-based arteriovenous malformation (AVM) score (RBAS) is a grading system designed to predict patient outcomes after Gamma Knife surgery for AVMs. This study seeks to validate independently the predictive nature of the RBAS, not only after single treatment but for retreatment, and to assess the overall outcome regardless of number of radiosurgeries. Results. Testing demonstrated that the RBAS correlated with excellent outcomes after single or repeat radiosurgery (p < 0.001 for both variables). One hundred sixty-two (49%) of 330 patients had excellent outcomes (obliteration without deficit) after a single treatment. Excellent outcomes were achieved in 74, 64, 50, and 11% of patients with AVM scores of < 1.0 (Group 1), between 1.0 and < 1.8 (Group 2), between 1.8 and < 2.5 (Group 3), and ≥ 2.5 (Group 4), respectively. Fifty-one patients (70%) obtained radiosurgical cure and 46 (63%) achieved excellent outcomes after repeat radiosurgery. Of these, 100% achieved excellent outcomes in Group 1, 70% did so in Group 2, 47% in Group 3, and 14% in Group 4. The RBAS correlated with excellent outcomes after overall treatment (p < 0.001). Two hundred seventy-seven patients (69%) obtained AVM obliteration, and 62% achieved excellent outcomes. In Group 1, 87% achieved excellent outcomes, 75% did so in Group 2, 61% in Group 3, and 24% in Group 4.
ture as a valid tool for predicting AVM obliteration after radiosurgery, as well as complications after microsurgery. [21] [22] [23] [24] [35] [36] [37] [38] 43, 55 Pollock and Flickinger 39 developed the RBAS in 2002 from a multivariate analysis of predictive factors of outcome after radiosurgery in a group of 220 patients at the University of Pittsburgh. Patient age (in years), AVM volume (in cm 3 ), and specific AVM location were evaluated in a separate group of 136 patients who underwent a single treatment with GKS. It was demonstrated that the RBAS could accurately predict excellent patient outcomes (complete obliteration with no new neurological deficit) after single-treatment radiosurgery, whereas the modified Spetzler-Martin score could not. 39 Since its development, other centers have demonstrated that the RBAS can accurately predict patient outcomes after radiosurgery 2, 8, 10, 28, 34, 39, 42 with the GKS 39, 42 and LINAC 2, 28, 34 systems, proving the AVM grading system to be a valid instrument in predicting patient outcomes, particularly in patients with deep 3, 41 AVMs. The purpose of this article is to validate independently the predictive nature of the RBAS in patients who underwent LINAC radiosurgery for intracranial AVMs at the University of Florida. In addition, we wanted to investigate the validity of the RBAS, not only for single radiosurgery treatments, but for retreatment, and for overall radiosurgical outcome, regardless of the number of radiosurgeries.
Methods

Patient Population
Between May 18, 1988 , and June 24, 2008 , 620 AVMs were treated with stereotactic radiosurgery at the University of Florida by using a modified LINAC system. 33 There were 309 male and 311 female patients in the population. The mean age was 40 years (range 4-78 years) and the mean treatment volume was 7 cm 3 (range 0.1-52.3 cm 3 ). The mean radiation dose was 16.5 Gy (range 7.5-25 Gy). The number of isocenters varied from 1 to 16.
To be included in the study, patients had to have undergone follow-up angiography (45%) or MR imaging studies (55%) 2 or more years after AVM radiosurgery, to have undergone AVM resection, or to have died of complications after radiosurgery (hemorrhage or radiation necrosis). Three hundred thirty patients who underwent single-treatment AVM radiosurgery were included in the study. Seventy-three patients underwent repeat AVM radiosurgery and were analyzed separately. The entire patient group, regardless of radiosurgery treatment number, was also evaluated. All patients who experienced a radiation-induced complication (22) or postradiosurgery hemorrhage (38) were included in the study.
Two hundred seventeen patients (35%) were not included in this study. Patients were considered ineligible if they only had CT evidence of nidus obliteration (2%) or died for reasons unrelated to their AVM radiosurgery before annual follow-up imaging could be obtained (5%). Forty-six patients (7%) were receiving follow-up care at the time this study was performed. The remaining 130 patients (21%) were considered lost to follow-up.
The RBAS and the Spetzler-Martin Grade
The RBAS and patient outcomes were determined for all patients as described by Pollock and colleagues. 39, 42 Briefly, the RBAS is determined by the following equation: AVM score = (0.1 × volume in cm 3 ) + (0.02 × age in years) + (0.3 × location). The location values were assigned as follows: frontal/temporal = 0, parietal/occipital/ corpus callosum/cerebellar = 1, and basal ganglia/thalamus/brainstem = 2. When an AVM occupied multiple locations, fractional values were assigned according to the number of sites. The Spetzler-Martin system was assigned as classically described, 49 determined by eloquence of adjacent brain (noneloquent = 0, eloquent = 1); venous drainage (superficial only = 0, deep = 1); and AVM diameter (< 3 cm = 1; 3-6 cm = 2; > 6 cm = 3).
Radiosurgical Technique
All patients were treated using the University of Florida radiosurgical system on an outpatient basis. Patient variables were prospectively maintained in a computerized AVM database. The method of treatment used and details have been discussed in previous reports. 6, 13, 16, 17, 19, 20 Briefly described, patients reported to the neurosurgical clinic for examination the day before treatment. On the day of treatment, a stereotactic head ring was positioned after induction of local anesthesia and a thin-slice contrast-enhanced CT scan was obtained. Stereotactic CT scans are uploaded into computer software, and computerized dosimetry planning follows. 15, 18, 56 Radiation doses were determined based on lesion volume and location. Attempts were made to deliver 20 Gy to the periphery when this was thought to be safely possible. The 80% isodose lines were used with dose volumes for single isocenters, and 70% isodose lines were used for multiple isocenters.
Follow-Up Evaluation
All patients were encouraged to undergo angiographic studies at 3 years postradiosurgery, with MR imaging annually. For the purposes of this analysis, if MR imaging or angiography displayed thrombosis, the patient was considered cured. If at 3 years MR imaging or angiography showed residual nidus, then radiosurgery was considered a failure, and retreatment was advised.
Defining Patient Outcomes
Patient outcomes after radiosurgery were defined as excellent, good, fair, unchanged, poor, and death, as described by Pollock and Flickinger. 39 Excellent patient outcomes were defined as complete nidus obliteration and no new neurological deficit (that is, hemorrhage or radiationinduced complication). Good and fair outcomes were defined as complete nidus obliteration with either a minor deficit (that is, partial quadrantanopia, ataxia, or cranial nerve injury) that did not interfere with activities of daily living, or a major deficit (that is, hemiparesis, aphasia, or homonymous hemianopia) that resulted in a decline of functioning. Patients were considered unchanged if, after 24 months of follow-up imaging, their AVM was still patent and the patient had experienced no new neurological deficit (such as hemorrhage or radiation-induced complica-tion). Patient outcomes for repeat radiosurgery treatments were determined at the time of the second radiosurgery. Any patient with AVM patency and any deficit was considered to have a poor outcome.
Statistical Analysis
The major statistical end point was patient outcomes. Correlations between excellent outcomes and the RBAS were analyzed by computing the Spearman correlation coefficient. A correlation was considered significant when the associated p value was < 0.05.
Results
Initial Radiosurgery and Outcomes
Four hundred three patients who were treated with stereotactic radiosurgery performed using a modified LINAC system 33 at the University of Florida between May 18, 1988 , and June 24, 2008, and for whom there was adequate follow-up, were included in the study. The characteristics, age, AVM location, and the Spetzler-Martin grade for all patients are summarized in Table 1 .
For the 330 patients who underwent single-treatment radiosurgery, the mean AVM dose volume was 9.9 cm ). The median radiation dose was 15 Gy (range 7.5-25 Gy). The mean RBAS score was 2.0 (range 0.4-5.6). Table 2 outlines the patient outcomes after radiosurgery. Six percent of patients experienced a radiation-induced complication, and 8% experienced postradiosurgery hemorrhage. Overall, 55% of patients (180) obtained a complete obliteration, and 49% (162) achieved excellent outcomes from a single radiosurgical procedure. Seventy-three patients underwent repeat radiosurgery due to a patent nidus.
Repeat Radiosurgery and Outcomes
All patients with angiographic or MR evidence of nidus patency 36 months after initial radiosurgery were scheduled for retreatment. These patients were considered to have reached a definite failure point, and the AVM outcome was considered unchanged. Seventy-three patients underwent repeat radiosurgery. The mean AVM dose volume was 5.7 cm 3 (range 0.2-37.3 cm 3 ). The median radiation dose was 15 Gy (range 10-20 Gy). The mean RBAS was 1.7 (range 0.6-4.8). Of the 73 patients undergoing repeat treatment, 4 (5%) experienced radiation-induced complications, and 5 (7%) experienced postradiosurgery hemorrhage. Two patients died due to postradiosurgery complications with hemorrhage. Complete AVM obliteration was confirmed for 51 (70%) of 73 patients. Sixtythree percent of patients achieved an excellent outcome after repeat radiosurgery (Table 2) .
Overall Radiosurgical Outcomes
With respect to total radiosurgical care, 403 patients underwent one or more radiosurgical procedures, and were evaluated, per their initial RBAS and their most recent AVM obliteration/follow-up status. The mean AVM dose volume was 9.1 cm 3 (range 0.1-46.2 cm ). The median radiation dose was 15 Gy (range 7.5-25 Gy). The mean RBAS was 1.9 (range 0.4-5.6). Overall, 22 patients (6%) experienced a radiation-induced complication, and 29 patients (7%) experienced a postradiosurgery hemorrhage. Two percent of patients (10 individuals) died due to complications following radiosurgery. Complete AVM obliteration was achieved in 277 patients (69%) after one or more radiosurgical procedures. Two hundred fifty patients (62%) obtained an excellent outcome.
Testing the Radiosurgery-Based AVM Score
The AVM grading system originally developed and tested in patients undergoing single-treatment GKS was tested in 3 individual sample populations from the University of Florida. Patient RBAS scores were divided into 4 groups: Group 1 (score < 1.0), Group 2 (score 1.0 < 1.8), Group 3 (score 1.8 < 2.5), and Group 4 (score ≥ 2.5). Significant correlations were found within all sample populations (Fig. 1) . For single-treatment radiosurgery, the rate of excellent outcome was 74% for Group 1, 64% for Group 2, 50% for Group 3, and 11% for Group 4 (Spearman correlation coefficient = −0.405, p < 0.001). The probability of an excellent outcome for patients undergoing repeat radiosurgery was 100% for Group 1, 70% for Group 2, 47% for Group 3, and 14% for Group 4 (Spearman correlation coefficient = −0.424, p < 0.001). For overall management, the probability of an excellent outcome was 87% for Group 1, 75% for Group 2, 61% for Group 3, and 24% for Group 4 (Spearman correlation coefficient = −0.390, p < 0.001).
Discussion
The purpose of this article was to validate independently the predictive nature of the RBAS in patients who underwent LINAC radiosurgery for intracranial AVMs at the University of Florida. In addition, we wanted to investigate the validity of predictions based on the score, not only for single radiosurgery treatments, but for retreatment and for overall radiosurgical care.
Factors Predictive of AVM Obliteration-Previous Reports
Many investigators have shown various factors to be predictive of AVM obliteration after radiosurgery. In 1997, Karlsson et al. 26 published an analysis aimed at defining predictive factors for AVM obliteration. Analyzing a 945-patient subset of 1319 patients with AVMs treated with GKS between 1970 and 1990, they identified peripheral dose as the most significant factor. The higher the minimum dose, the higher the obliteration rate, up to 25 Gy. Higher average dose and smaller AVM volume were also found to be predictive. From their data came the K index, which correlated with obliteration up to a value of 27, at which no further improvement was observed.
In 1998, Pollock and colleagues 40 found that the following factors predicted success: lower AVM volume, fewer draining veins, younger patient age, and more superficial lesion location. Prior embolization of the AVM was a negative predictor. In an earlier analysis by the same group, 14 the dose to the periphery of the target was found to be the most significant predictor of success. Neither volume nor maximum dose was found to be predictive.
In 2000, Chang et al. 9 reported on 128 patients who were followed for at least 2 years after GKS. In a multivariate analysis, maximum diameter, diffuse nidus shape, and a single draining vein were significantly related to complete obliteration/cure.
Reporting on their Tokyo experience, Shin et al. 46 retrospectively analyzed follow-up data from 400 patients with AVMs treated between 1990 and 1999 with GKS. The authors found that hemorrhage before radiosurgery, smaller nidus diameter, and higher margin dose were significantly related to obliteration when subjected to a multivariate analysis. Of the 254 patients in whom obliteration was achieved, in 229 patients it occurred within 3 years; therefore, factors significant for early obliteration were investigated. Again, hemorrhage before radiosurgery, smaller nidus diameter, and male sex were found to be significant factors after multivariate analysis.
In 2004, Maruyama et al. 32 reported on 50 patients who underwent GKS between 1987 and 2002 for brainstem AVMs. After univariate and multivariate analysis, these investigators found a significant relationship between 2 or fewer isocenters used and obliteration.
In 2005, Zabel et al. 54 reported a retrospective analysis of factors affecting obliteration rate after radiosurgery in 110 patients. Radiation dose and AVM localization were also found to correlate significantly with obliteration. Female sex was noted to be significantly associated with complete obliteration, with age showing no influence on cure rate. Complete obliteration was significantly higher in patients with AVMs < 3 cm in diameter. These authors concluded that only the Spetzler-Martin grade remained significant after performing multivariate analysis, and that those patients with an RBAS < 1.0 showed Fig. 1 . Graphs showing the correlation between RBAS and the proportion of patients achieving excellent outcome after a single radiosurgery (A), repeat radiosurgery (B), and overall radiosurgery (C). ≤1 (71) <1 (74) <1 (100) <1 (87) >2 (39) 1-1.49 (74)
1.4-1.7 (50) >1 (52) >1.9 (48) >1 ( "a trend towards better chance of obliteration" versus patients with an RBAS > 2.0 (68 vs 40%). Friedman and colleagues have published multiple reports on the University of Florida experience with radiosurgery. In 1998, Ellis et al. 13 reported on the results of 72 patients with angiographically confirmed obliteration. After multivariate analysis, it was found that increased AVM size, decreased treatment dose, and increased Spetzler-Martin grade were statistically significant predictors of nonobliteration. In 2003, Friedman et al. 18 performed an exhaustive analysis of factors thought to be predictive of success in AVM radiosurgery. From the 269 patients whose cases were reviewed, it was found that higher Spetzler-Martin grades were correlated with radiological failure. Higher radiation doses were correlated with radiological success, and higher dose gradients were correlated with success. In 2004, Zipfel and colleagues 56 explored the effect of AVM morphological characteristics on radiosurgical success. In addition to a number of AVM-specific factors, patient factors such as age, presenting symptoms, radiation dose, and repeat treatment were included in the analysis. In 268 patients, these investigators found that "diffuse nidus morphology" and "neovascularity" were statistically significant predictors of obliteration failure, noting that a higher radiosurgical dose was strongly correlated with neuroimaging-defined success.
Radiosurgery-Based AVM Score
In an effort to extend the application of obliteration rate data clinically, grading scales have been developed that incorporate predictive factors for AVM obliteration, most notably the Spetzler-Martin grading system. 49 The Spetzler-Martin scale has been the predominant scale used for predicting AVM obliteration, and has been independently validated. [21] [22] [23] [24] 35, 38, 43, 55 The RBAS was created to account for these deficits. The radiosurgery-based score developed by Pollock and Flickinger has been found to be reliable in quantifying AVM obliteration rates and percent chance of excellent outcomes in patients harboring intracranial AVMs. The RBAS can facilitate the decision-making process for treatment (radiosurgery vs microsurgery) and can allow the neurosurgeon to provide further detail about outcomes to patients prior to radiosurgery. Note that all variables are independent of dose planning, and that they account for patient characteristics. The radiosurgery-based score has been proven to be useful in predicting patient outcomes resulting from both the GKS 39, 42 and LINAC 2,28,34 radiosurgical systems, and previous authors have conferred clinical significance to the RBAS by grouping AVM scores, which may allow for a better comparison between AVMs and outcome.
Evaluating the Radiosurgery-Based AVM Score-Previous Reports
In Table 3 , the results in this series are compared with those in other reports regarding the radiosurgery-based AVM score.
Conclusions
The aim of this study was to provide independent validation of the predictive nature of the RBAS in patients who underwent LINAC radiosurgery for intracranial AVMs at the University of Florida. In addition, we wanted to observe the scores' validity, not only for single radiosurgery treatments, but for retreatment and for overall radiosurgical care. We have reached the following conclusions. 1) The RBAS correlates well with patients receiving repeat AVM radiosurgery via a LINAC radiosurgical system. 2) The RBAS correlates with both single and overall treatment in patients harboring AVMs. 3) Variability in reporting exists when adjusting probabilities for excellent outcomes in subdivided groups. We chose our group cutoff points (that is, 1.0, 1.8, and 2.5) in an effort to divide radiosurgery scores evenly, and suggest that further studies do the same. 4) We suggest continued follow-up of patients who undergo radiosurgery for their AVMs. Due to the latency inherent with radiosurgical obliteration, the potential for complications remains, even years beyond treatment. This could revert a onceexcellent outcome back to fair, unchanged, and so on. This inevitably would impact the final correlated results of AVM radiosurgery.
Overall, outcomes in single, repeat, and overall radiosurgery are accurately predicted using the radiosurgerybased grading scale according to the described method. Complication rates and percentages of excellent outcomes attained using this method were similar to those in previously published reports. It appears that this score could be used on a case-by-case basis to help physicians and patients better understand the expected results of LINACbased AVM radiosurgery.
Disclaimer
